Pharis Mohideen
2022 - DBV Technologies S.A.
In 2022, Pharis Mohideen earned a total compensation of $1.1M as Chief Medical Officer at DBV Technologies S.A., a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,120 |
|---|---|
| Option Awards | $258,444 |
| Salary | $515,000 |
| Stock Awards | $93,243 |
| Total | $1,076,807 |
Mohideen received $515K in salary, accounting for 48% of the total pay in 2022.
Mohideen also received $210.1K in non-equity incentive plan, $258.4K in option awards and $93.2K in stock awards.
Rankings
In 2022, Pharis Mohideen's compensation ranked 2,879th out of 5,756 executives tracked by ExecPay. In other words, Mohideen earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,879 out of 5,756 | 50th |
Division Manufacturing | 1,605 out of 3,133 | 49th |
Major group Chemicals And Allied Products | 744 out of 1,419 | 48th |
Industry group Drugs | 694 out of 1,320 | 47th |
Industry Biological Products, Except Diagnostic Substances | 167 out of 291 | 43rd |
Source: SEC filing on March 24, 2023.
Mohideen's colleagues
We found two more compensation records of executives who worked with Pharis Mohideen at DBV Technologies S.A. in 2022.